Applied Cognition Overview
- Year Founded
-
2020
- Status
-
Private
- Employees
-
19
- Latest Deal Type
-
Later Stage VC
- Investors
-
7
Applied Cognition General Information
Description
Developer of glymphatic system measurement and therapeutic technologies designed to enable disease detection and treatment in neurological disorders. The company provides a non-invasive, real-time monitoring platform to assess glymphatic function and develops drug candidates targeting conditions such as Alzheimer's, Parkinson's, and post-traumatic headaches, enabling healthcare and biopharmaceutical stakeholders to advance precision diagnostics and neurodegenerative disease therapies.
Contact Information
Website
www.appliedcognition.comCorporate Office
- 1629 Main Street
- Redwood City, CA 94063
- United States
Corporate Office
- 1629 Main Street
- Redwood City, CA 94063
- United States
Applied Cognition Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 2. Later Stage VC | 01-Jul-2026 | Completed | Clinical Trials - General | |||
| 1. Seed Round | 25-Oct-2021 | Completed | Clinical Trials - General |
Applied Cognition Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Seed Prime | ||||||||
| Seed |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Applied Cognition Patents
Applied Cognition Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-12648931-B2 | Compositions, formulations, and methods of treating neurodegenerative diseases | Active | 27-Jun-2024 | ||
| US-20260000647-A1 | Compositions, formulations, and methods of treating neurodegenerative diseases | Active | 27-Jun-2024 | ||
| US-20260263420-A1 | Compositions, formulations, and methods of treating neurodegenerative diseases | Pending | 27-Jun-2024 | ||
| WO-2026006766-A1 | Compositions, formulations, and methods of treating neurodegenerative diseases | Pending | 27-Jun-2024 | ||
| AU-2023367575-A1 | Non-invasive topographic localization of glymphatic flow | Pending | 24-Oct-2022 | A61B5/4064 |
Applied Cognition Signals
Applied Cognition Investors (7)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Supermoon Capital | Venture Capital | Minority | ||
| A&E Investments | Venture Capital | Minority | ||
| BroadVision Group | Venture Capital | Minority | ||
| GreyMatter (US) | Venture Capital | Minority | ||
| Mayfield Fund | Venture Capital | Minority |
Applied Cognition FAQs
-
When was Applied Cognition founded?
Applied Cognition was founded in 2020.
-
Where is Applied Cognition headquartered?
Applied Cognition is headquartered in Redwood City, CA.
-
What is the size of Applied Cognition?
Applied Cognition has 19 total employees.
-
What industry is Applied Cognition in?
Applied Cognition’s primary industry is Biotechnology.
-
Is Applied Cognition a private or public company?
Applied Cognition is a Private company.
-
What is Applied Cognition’s current revenue?
The current revenue for Applied Cognition is .
-
How much funding has Applied Cognition raised over time?
Applied Cognition has raised $22.5M.
-
Who are Applied Cognition’s investors?
Supermoon Capital, A&E Investments, BroadVision Group, GreyMatter (US), and Mayfield Fund are 5 of 7 investors who have invested in Applied Cognition.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process